L C Bartos

597 total citations
10 papers, 543 citations indexed

About

L C Bartos is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, L C Bartos has authored 10 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 5 papers in Microbiology and 4 papers in Infectious Diseases. Recurrent topics in L C Bartos's work include Bacterial Infections and Vaccines (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and HIV/AIDS drug development and treatment (4 papers). L C Bartos is often cited by papers focused on Bacterial Infections and Vaccines (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and HIV/AIDS drug development and treatment (4 papers). L C Bartos collaborates with scholars based in United States. L C Bartos's co-authors include Timothy F. Murphy, Michael A. Apicella, Michael Nelson, Peter A. Rice, Kathleen C. Dudas, Anthony A. Campagnari, Gene D. Morse, Mark Shelton, Alice O’Donnell and Raffaele D’Ambrosio and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

L C Bartos

10 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L C Bartos United States 10 341 304 98 90 69 10 543
Edward R. Leake United States 7 274 0.8× 242 0.8× 94 1.0× 30 0.3× 46 0.7× 8 428
Lucimar G. Milagres Brazil 12 425 1.2× 445 1.5× 52 0.5× 35 0.4× 58 0.8× 43 606
Joseph Kuo United States 13 199 0.6× 265 0.9× 100 1.0× 52 0.6× 94 1.4× 27 494
J R Gilsdorf United States 18 517 1.5× 340 1.1× 267 2.7× 136 1.5× 47 0.7× 34 742
Leena Saarinen Finland 15 350 1.0× 392 1.3× 69 0.7× 64 0.7× 51 0.7× 19 533
J. Nagel Netherlands 15 294 0.9× 306 1.0× 114 1.2× 109 1.2× 110 1.6× 31 675
David E. Briles United States 15 428 1.3× 805 2.6× 121 1.2× 76 0.8× 101 1.5× 18 1.1k
Mayuri Patel United States 11 267 0.8× 405 1.3× 88 0.9× 31 0.3× 93 1.3× 31 549
B. L. Brandt United States 17 919 2.7× 829 2.7× 127 1.3× 72 0.8× 69 1.0× 24 1.1k
Kyungcheol Yi United States 10 182 0.5× 127 0.4× 79 0.8× 26 0.3× 21 0.3× 10 352

Countries citing papers authored by L C Bartos

Since Specialization
Citations

This map shows the geographic impact of L C Bartos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L C Bartos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L C Bartos more than expected).

Fields of papers citing papers by L C Bartos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L C Bartos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L C Bartos. The network helps show where L C Bartos may publish in the future.

Co-authorship network of co-authors of L C Bartos

This figure shows the co-authorship network connecting the top 25 collaborators of L C Bartos. A scholar is included among the top collaborators of L C Bartos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L C Bartos. L C Bartos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
D’Ambrosio, Raffaele, et al.. (1997). Radioimmunoassay of Zidovudine. Therapeutic Drug Monitoring. 19(2). 195–200. 9 indexed citations
2.
Morse, Gene D., et al.. (1995). Pharmacokinetics of zidovudine and didanosine during combination therapy1. Antiviral Research. 27(4). 419–424. 11 indexed citations
3.
Lawrence, W. Dwayne, et al.. (1993). Pharmacokinetics and pharmacodynamics of granulocyte-macrophage colony-stimulating factor and zidovudine in patients with AIDS and severe AIDS-related complex. Antimicrobial Agents and Chemotherapy. 37(3). 512–522. 16 indexed citations
4.
Morse, Gene D., et al.. (1993). Zidovudine Pharmacokinetics in HIV‐Positive Women During Different Phases of the Menstrual Cycle. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 13(4). 369–377. 22 indexed citations
5.
Murphy, Timothy F. & L C Bartos. (1989). Surface-exposed and antigenically conserved determinants of outer membrane proteins of Branhamella catarrhalis. Infection and Immunity. 57(10). 2938–2941. 80 indexed citations
6.
Bartos, L C & Timothy F. Murphy. (1988). Comparison of the Outer Membrane Proteins of 50 Strains of Branhamella catarrhalis. The Journal of Infectious Diseases. 158(4). 761–765. 77 indexed citations
7.
Murphy, Timothy F. & L C Bartos. (1988). Purification and analysis with monoclonal antibodies of P2, the major outer membrane protein of nontypable Haemophilus influenzae. Infection and Immunity. 56(5). 1084–1089. 54 indexed citations
8.
Murphy, Timothy F. & L C Bartos. (1988). Human bactericidal antibody response to outer membrane protein P2 of nontypeable Haemophilus influenzae. Infection and Immunity. 56(10). 2673–2679. 69 indexed citations
9.
Murphy, Timothy F., L C Bartos, Peter A. Rice, et al.. (1986). Identification of a 16,600-dalton outer membrane protein on nontypeable Haemophilus influenzae as a target for human serum bactericidal antibody.. Journal of Clinical Investigation. 78(4). 1020–1027. 117 indexed citations
10.
Murphy, Timothy F., L C Bartos, Anthony A. Campagnari, Michael Nelson, & Michael A. Apicella. (1986). Antigenic characterization of the P6 protein of nontypable Haemophilus influenzae. Infection and Immunity. 54(3). 774–779. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026